Lifetime vigorous physical activity may be beneficial in lowering risk for non-Hodgkin lymphoma
the ONA take:
Level of physical activity over a lifetime can impact risk for non-Hodgkin lymphoma (NHL).
In a study from the Department of Cancer Control Research at the British Columbia (BC) Cancer Agency and the School of Population and Public Health at the University of British Columbia in Canada, researchers investigated the impact of vigorous physical activity on risk of NHL.
Risk of some cancers, such as breast and colon cancers, is lower in people who are physically active, and these researchers sought evidence of a similar association for NHL.
The study was conducted using data from a case-control study that recruited 820 patients with NHL of various ages from the BC Cancer Registry and 848 randomly selected controls matched for age, gender, and residential location from the Client Registry of the British Columbia Ministry of Health.
Study participants in the second and higher quartiles of vigorously intense physical activity performance had lower risk for NHL compared with those in the first quartile of vigorously intense physical activity performance.
Although research to date is not sufficient to confidently state that vigorous physical activity can reduce risk for NHL, these findings indicate that vigorous physical activity is beneficial in terms of risk for this disease.
That different types of NHL have different risk factors is known, so the researchers are planning to investigate whether physical activity influences the risk for different types of NHL in different ways.
Level of physical activity over a lifetime can impact risk for non-Hodgkin lymphoma.
- Novel Colonoscopy Prep Is Poised to Improve Screening Rates for Colon Cancer
- PPIs Negatively Impact Outcomes of Patients Treated With Capecitabine
- How Physical Changes From Breast Cancer Affect Self-Image: Considerations for Clinicians
- Panobinostat Modestly Improves OS in Relapsed Multiple Myeloma
- Short-Term Intervention May Have Long-term Diet Effect in Hispanic Breast Cancer Survivors
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Implementing a Distress Screening Process for Cancer Patients
- Initiating Palliative Care in the Emergency Department
- New Research Identifies Potential Bladder Cancer Chemotherapy Side Effect
- Pseudohyperkalemia: False Potassium Levels Occur in a Patient With Lymphoma
- Atezolizumab Granted FDA Approval for Specific Cases of NSCLC
- Low-Dose Sublingual Fentanyl Safe, Effective in Patients Receiving Lower Opioid Doses
- High U.S. Economic Burden for Vaccine-Preventable Diseases
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|